BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Cadila Pharma Launches API Manufacturing Plant at Dahej November 29, 2023 The total investment to set up this facility is around INR 200 Cr. Further, the facility is designed with advanced technologies including the latest Distributed Control System (DCS) automation technology.
Rusan Pharma Launches API Facility in Madhya Pradesh with INR 300 Cr Investment November 27, 2023 The newly launched facility is designed to meet international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tonnes of APIs annually.
Indian Govt Approves 51 Pharmaceutical Cos for PLI Scheme October 30, 2023 Indian Government's PLI Scheme greenlights 51 pharma companies to reduce dependency on imported APIs, marking a pivotal stride toward self-sufficiency and strengthening the 'Make in India' vision.
WiStride Launches its Intelligence-Powered B2B App October 9, 2023 WiStride, India's first-ever intelligence-powered integrated B2B platform for active pharmaceutical ingredients (APIs), intermediates and raw materials, has launched its digital platform.
Kotak Fund to Invest INR 1,600 Cr in Nimmagadda Prasad's API Biz October 9, 2023 India's Kotak Mahindra Group asset management arm, Kotak Strategic Situations Fund (KSSF) has planned to invest around INR 1,600 Cr in the recently acquired active pharmaceutical ingredients (API) business by Nimmagadda Prasad, from Viatris last week.
Pharma Czar Nimagadda aka 'Matrix' Prasad-Backed IQuest Enterprises Acquires Viatris' Indian API Biz October 3, 2023 IQuest Enterprises, a Hyderabad-based investment firm, promoted by Nimmagadda Prasad, has entered into a definitive agreement to acquire the active pharmaceutical ingredients (API) business of global pharmaceutical major Viatris in India.
Indian CPG Company Nirma to Acquire Glenmark Life Sciences for INR 5,651 Cr September 25, 2023 Ahmedabad-based Nirma has agreed to acquire 75% of Glenmark's active pharmaceutical ingredient (API) unit Glenmark Life Sciences (GLS), with the deal valued at INR 5,651.5 Cr, or INR 615 per share.
IndiaRF to Acquire Ind-Swift's API, CRAMS Units for INR 1650 Cr September 7, 2023 In a deal with BlackSoil, a prominent investment firm, GenWorks Health has received $4 million in funding. Through this investment, GenWorks Health can provide quality healthcare in underserved areas.
Page 1 of 1
